世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034268

網膜治療薬の世界市場(2023-2027)

TechNavio

Global Retinal Drugs Market 2023-2027

発刊日 2023/01/23

言語英語

体裁PDF/167ページ

ライセンス/価格167ページ

0000034268

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、網膜治療薬市場を分析します。

世界の網膜治療薬市場は、予測期間中に約6.27 %のCAGRで加速し、2022年から2027年の間に72億7,579万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。網膜疾患の有病率の上昇、高度な診断ツールの出現、患者支援プログラムなどが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 適応症別
      ◇ 黄斑変性症
      ◇ 糖尿病性眼疾患
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、革新的な治療法の開発が、今後数年間の網膜治療薬市場の成長を促進する主な理由の 1 つであることを特定しています。また、徐放性眼科用製剤の需要の高まりと診断技術の進歩により、市場でかなりの需要が生じるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 網膜治療薬の市場規模
  • 網膜治療薬の市場予測
  • 網膜治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な網膜治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Bayer AG, AbbVie Inc.
    ➣ Alcon Inc
    ➣ Alimera Sciences Inc.
    ➣ Bausch Health Co Inc.
    ➣ Bristol Myers Squibb Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Kubota Corp.
    ➣ MeiraGTx Holdings Plc
    ➣ Novartis A
    ➣ Ocular Therapeutix Inc.
    ➣ Oxurion NV
    ➣ Pfizer Inc.
    ➣ Regeneron Pharmaceuticals Inc.
    ➣ REGENXBIO Inc.
    ➣ Sanofi SA
    ➣ Santen Pharmaceutical Co. Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Visufarma
    ➣ Johnson and Johnson Services Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global retinal drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global retinal drugs market 2017 - 2021 ($ million)
4.2 Ditribution channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Ditribution channel Segment 2017 - 2021 ($ million)
4.3 Indication Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
6.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Indication
7.1 Market segments
Exhibit 47: Chart on Indication - Market share 2022-2027 (%)
Exhibit 48: Data Table on Indication - Market share 2022-2027 (%)
7.2 Comparison by Indication
Exhibit 49: Chart on Comparison by Indication
Exhibit 50: Data Table on Comparison by Indication
7.3 Macular degeneration - Market size and forecast 2022-2027
Exhibit 51: Chart on Macular degeneration - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Macular degeneration - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Macular degeneration - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Macular degeneration - Year-over-year growth 2022-2027 (%)
7.4 Diabetic eye disease - Market size and forecast 2022-2027
Exhibit 55: Chart on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Indication
Exhibit 63: Market opportunity by Indication ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share by geography 2022-2027 (%)
Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Spain - Market size and forecast 2022-2027
Exhibit 97: Chart on Spain - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Spain - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Spain - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Spain - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 112: AbbVie Inc. - Overview
Exhibit 113: AbbVie Inc. - Product / Service
Exhibit 114: AbbVie Inc. - Key news
Exhibit 115: AbbVie Inc. - Key offerings
12.4 Alcon Inc.
Exhibit 116: Alcon Inc. - Overview
Exhibit 117: Alcon Inc. - Business segments
Exhibit 118: Alcon Inc. - Key offerings
Exhibit 119: Alcon Inc. - Segment focus
12.5 Alimera Sciences Inc.
Exhibit 120: Alimera Sciences Inc. - Overview
Exhibit 121: Alimera Sciences Inc. - Product / Service
Exhibit 122: Alimera Sciences Inc. - Key offerings
12.6 Bausch Health Co Inc.
Exhibit 123: Bausch Health Co Inc. - Overview
Exhibit 124: Bausch Health Co Inc. - Business segments
Exhibit 125: Bausch Health Co Inc. - Key news
Exhibit 126: Bausch Health Co Inc. - Key offerings
Exhibit 127: Bausch Health Co Inc. - Segment focus
12.7 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 133: Bristol Myers Squibb Co. - Overview
Exhibit 134: Bristol Myers Squibb Co. - Product / Service
Exhibit 135: Bristol Myers Squibb Co. - Key news
Exhibit 136: Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Johnson and Johnson Services Inc.
Exhibit 142: Johnson and Johnson Services Inc. - Overview
Exhibit 143: Johnson and Johnson Services Inc. - Business segments
Exhibit 144: Johnson and Johnson Services Inc. - Key news
Exhibit 145: Johnson and Johnson Services Inc. - Key offerings
Exhibit 146: Johnson and Johnson Services Inc. - Segment focus
12.11 MeiraGTx Holdings Plc
Exhibit 147: MeiraGTx Holdings Plc - Overview
Exhibit 148: MeiraGTx Holdings Plc - Product / Service
Exhibit 149: MeiraGTx Holdings Plc - Key offerings
12.12 Novartis AG
Exhibit 150: Novartis AG - Overview
Exhibit 151: Novartis AG - Business segments
Exhibit 152: Novartis AG - Key offerings
Exhibit 153: Novartis AG - Segment focus
12.13 Ocular Therapeutix Inc.
Exhibit 154: Ocular Therapeutix Inc. - Overview
Exhibit 155: Ocular Therapeutix Inc. - Product / Service
Exhibit 156: Ocular Therapeutix Inc. - Key offerings
12.14 Oxurion NV
Exhibit 157: Oxurion NV - Overview
Exhibit 158: Oxurion NV - Product / Service
Exhibit 159: Oxurion NV - Key offerings
12.15 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product / Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.16 Regeneron Pharmaceuticals Inc.
Exhibit 164: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 165: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 166: Regeneron Pharmaceuticals Inc. - Key offerings
12.17 Sanofi SA
Exhibit 167: Sanofi SA - Overview
Exhibit 168: Sanofi SA - Business segments
Exhibit 169: Sanofi SA - Key news
Exhibit 170: Sanofi SA - Key offerings
Exhibit 171: Sanofi SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global retinal drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Ditribution channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Chart on Indication - Market share 2022-2027 (%)
Exhibits48: Data Table on Indication - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Indication
Exhibits50: Data Table on Comparison by Indication
Exhibits51: Chart on Macular degeneration - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Macular degeneration - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Macular degeneration - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Macular degeneration - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Indication ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share by geography 2022-2027 (%)
Exhibits66: Data Table on Market share by geography 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Spain - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Spain - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Spain - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Spain - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity by geography ($ million)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: AbbVie Inc. - Overview
Exhibits113: AbbVie Inc. - Product / Service
Exhibits114: AbbVie Inc. - Key news
Exhibits115: AbbVie Inc. - Key offerings
Exhibits116: Alcon Inc. - Overview
Exhibits117: Alcon Inc. - Business segments
Exhibits118: Alcon Inc. - Key offerings
Exhibits119: Alcon Inc. - Segment focus
Exhibits120: Alimera Sciences Inc. - Overview
Exhibits121: Alimera Sciences Inc. - Product / Service
Exhibits122: Alimera Sciences Inc. - Key offerings
Exhibits123: Bausch Health Co Inc. - Overview
Exhibits124: Bausch Health Co Inc. - Business segments
Exhibits125: Bausch Health Co Inc. - Key news
Exhibits126: Bausch Health Co Inc. - Key offerings
Exhibits127: Bausch Health Co Inc. - Segment focus
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Bristol Myers Squibb Co. - Overview
Exhibits134: Bristol Myers Squibb Co. - Product / Service
Exhibits135: Bristol Myers Squibb Co. - Key news
Exhibits136: Bristol Myers Squibb Co. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: Johnson and Johnson Services Inc. - Overview
Exhibits143: Johnson and Johnson Services Inc. - Business segments
Exhibits144: Johnson and Johnson Services Inc. - Key news
Exhibits145: Johnson and Johnson Services Inc. - Key offerings
Exhibits146: Johnson and Johnson Services Inc. - Segment focus
Exhibits147: MeiraGTx Holdings Plc - Overview
Exhibits148: MeiraGTx Holdings Plc - Product / Service
Exhibits149: MeiraGTx Holdings Plc - Key offerings
Exhibits150: Novartis AG - Overview
Exhibits151: Novartis AG - Business segments
Exhibits152: Novartis AG - Key offerings
Exhibits153: Novartis AG - Segment focus
Exhibits154: Ocular Therapeutix Inc. - Overview
Exhibits155: Ocular Therapeutix Inc. - Product / Service
Exhibits156: Ocular Therapeutix Inc. - Key offerings
Exhibits157: Oxurion NV - Overview
Exhibits158: Oxurion NV - Product / Service
Exhibits159: Oxurion NV - Key offerings
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Regeneron Pharmaceuticals Inc. - Overview
Exhibits165: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits166: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations

この商品のレポートナンバー

0000034268

TOP